Savvyn
Savvyn is an AI-driven software platform that automates evidence aggregation, payer and HTA requirements tracking, and complex submissions for Medical Affairs and Market Access teams in diagnostics, medical devices, and therapeutics. The platform continuously ingests new publications and payer policy updates, tracing every claim back to its source sentence for auditability.
- Healthcare Technology
- Data & Analytics
- Artificial Intelligence
- Software Only
- Biotechnology
- Hardware
- Medical Devices
- Regulatory & Compliance Technology
Funding
Founders
Founder details are not available yet.
Product
Problem
Diagnostics and medical device companies struggle to understand what clinical evidence is needed to secure regulatory approval and payer coverage, often leading to delayed market access or denied claims. Misalignment between evidence being generated and payer or regulatory expectations remains a core challenge.
Solution
Savvyn is AI-driven software that tracks a company’s existing evidence, prior competitor approvals, and current payer decisions to show what is required next. It analyzes studies, publications, regulatory submissions, and operational data to map coverage landscapes, identify evidence gaps, and assess submission readiness. The platform produces dossier sections, denial responses, and coverage-facing documents, reducing the manual burden of evidence compilation and strategy planning. Savvyn runs continuously, ingesting new publications and payer policy updates in real time to keep its analyses current, and every claim is traced back to its source sentence for auditability.
Target Audience
Primary users are early-stage and in-market teams in diagnostics, medical device, and digital health companies working in medical affairs, market access, and regulatory strategy.
Features
- AI-driven evidence gap analysis built from trial reports, publications, regulatory submissions, and grant applications
- Coverage landscape mapping for specific indications and intended use cases, benchmarked against Medicare and commercial payer policies
- Competitor evidence tracking to benchmark against previously approved products across analytical validity, clinical validity, and clinical utility domains
- Submission readiness assessments with remediation recommendations and feasibility timelines
- Denial response drafting supported by existing study data, with graded uncertainty and citation-level traceability
- Self-updating dossier sections that automatically flag changes when new evidence or payer policies are ingested
- Real-time monitoring of payer policy updates and new publications with automated flagging for review